| Literature DB >> 15652402 |
Kazumasa Okada1, Etsushi Kuroda, Yasuhiro Yoshida, Uki Yamashita, Akio Suzumura, Sadatoshi Tsuji.
Abstract
The effects of interferon (IFN)-beta used for treatment of multiple sclerosis (MS) on the central nervous system (CNS) have not yet been elucidated. The effect of IFN-beta and IFN-gamma on astrocytes as the major component of the CNS was investigated using murine primary astrocytes and human astrocytoma U251 cell line. IL-1beta, IL-6, TNF-alpha and iNOS were analyzed by RT-PCR. Both protein and mRNA levels of IL-6 were increased by IFN-beta. IFN-gamma augmented the effect of IFN-beta on IL-6 production. These results suggest that IFN-beta has an activity to modulate inflammatory and immune responses by up-regulating IL-6 in the CNS of MS.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15652402 DOI: 10.1016/j.jneuroim.2004.09.013
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478